Literature DB >> 15200061

Solitary osteochondroma arising from the thoracic facet joint--case report.

Arvind G Kulkarni1, Atul Goel, Dattatraya Muzumdar.   

Abstract

A 15-year-old male presented with pain in the back and paresthesia and weakness of both lower limbs progressing for 6 months. Magnetic resonance imaging revealed a mass lesion occupying the spinal canal at the T-10 to T-11 levels, which had severely compressed the cord. At surgery, a firm and cartilaginous tumor originating from the facet joint was radically excised. The patient showed rapid neurological recovery following the surgery. Histological examination revealed that the lesion was osteochondroma. Such lesions are extremely rare in the lower thoracic spine and osteochondroma arising from the thoracic facet joint is unique.

Entities:  

Mesh:

Year:  2004        PMID: 15200061     DOI: 10.2176/nmc.44.255

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  4 in total

1.  Solitary Osteochondroma of the Spine-A Case Series: Review of Solitary Osteochondroma With Myelopathic Symptoms.

Authors:  Ramakanth Yakkanti; Ikemefuna Onyekwelu; Leah Y Carreon; John R Dimar
Journal:  Global Spine J       Date:  2017-06-01

2.  Osteochondroma Arising From the Inferior Articular Process of the Lumbar Spine in a Geriatric Patient: A Case Report and Literature Review.

Authors:  Guang-Xun Lin; Hua-Jian Wu; Chien-Min Chen; Gang Rui; Bao-Shan Hu
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-01-25

3.  Solitary Pediatric Osteochondroma of the Spine With Cord Compression.

Authors:  Tania Mamdouhi; Prashin Unadkat; Morris C Edelman; Alan A Johnson; Carolyn Fein Levy; Mark A Mittler
Journal:  Cureus       Date:  2022-03-20

4.  Cervical radiculopathy due to disc herniation with adjacent facet hypertrophy: case report.

Authors:  Hitoshi Yamahata; Muneyoshi Yasuda; Tatsuro Aoyama; Koji Osuka; Kazunori Arita; Masakazu Takayasu
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-01-28       Impact factor: 1.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.